Codeine-containing cough medicines in UK to get new labels
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has recommended changes to the labelling and packaging of all codeine-containing oral liquid cough medicines that are sold over-the-counter. The agency states these should not used for treating children under 18 years old and should be sold in child-resistant containers1.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.